Were anxiety, depression and psychological distress associated with local mortality rates during COVID-19 outbreak in Italy? Findings from the COMET studyArticle Published on 2022-08-012023-07-09 Journal: Journal of psychiatric research [Category] COVID19(2023년), [키워드] Anxiety COVID-19 Depression mortality rate Psychological distress [DOI] 10.1016/j.jpsychires.2022.06.018 PMC 바로가기
Propolis efficacy on SARS-COV viruses: a review on antimicrobial activities and molecular simulationsSARS-COV 바이러스에 대한 프로폴리스 효능: 항균 활성 및 분자 시뮬레이션에 대한 검토Review Published on 2022-08-012022-09-11 Journal: Environmental science and pollution research inter [Category] COVID19(2023년), SARS, 치료제, [키워드] activities activity addition adjuvants Anti-inflammatory Anti-viral antimicrobial Antimicrobial activities appear biological properties combating Comorbidities Compound COVID-19 COVID-19 patient COVID-19 symptoms COVID-19 treatment COVID-19 vaccine discharge Efficacy evaluated flavonoids highlight hospitals immunomodulatory include investigated Molecular simulation molecular simulations mortality rate nutraceutical nutraceuticals patients Pharmacological properties Propolis provide receiving reduce viral replication reduced Research SARS-CoV viruses SARS-CoV-2 SARS-CoV-2 virus SARS-CoV-2-infected patients Symptom the SARS-CoV-2 virus Treatment Vaccine viral clearance viral replication while [DOI] 10.1007/s11356-022-21652-6 PMC 바로가기 [Article Type] Review
The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials코로나19 환자를 위한 중간엽 기질세포의 임상적 효능 및 안전성: 무작위 대조 시험의 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-08-012022-09-11 Journal: Journal of infection and public health [Category] 신약개발, 임상, [키워드] 28-day mortality 95% CI addition adverse event adverse events AEs appear Clinical efficacy Clinical improvement Clinical outcome clinical outcomes ClinicalTrials Cochrane Library control group controls COVID-19 help IMPROVE investigated Mesenchymal stromal cell Mesenchymal stromal cells Meta-analysis Mortality mortality rate MSC MSCs OVID Patient patients patients with COVID-19 Placebo placebos Randomized controlled trial Randomized controlled trials RCT RCTs risk Safe SARS-CoV-2 searched serious AE serious AEs significantly higher significantly lower stromal cell stromal cells systematic review therapeutic option treat Treatment [DOI] 10.1016/j.jiph.2022.07.001 PMC 바로가기 [Article Type] Meta-Analysis
Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trialRandomized Controlled Trial Published on 2022-08-012022-10-04 Journal: Inflammopharmacology [Category] COVID19(2023년), SARS, 임상, [키워드] accompanied addition administration admitted to ICU anti-inflammatory properties antioxidant Characteristics clinical complications Clinical improvement Clinical outcome control group coronavirus disease COVID-19 decrease Edaravone Endotracheal intubation Endpoint evaluate the effect Evaluating groups hallmark hospital ICUs immune response induce Injury intensive care unit intervention arms intervention group intravenous intubation Laboratory test mechanical ventilation Medical Science Mortality mortality rate National outcome overactive Patient Pneumonia Primary outcome Randomized randomized clinical trial receiving reduce secondary secondary endpoint severe COVID-19 severe COVID-19 patient single-center stimulate Tabriz therapy university viral infection [DOI] 10.1007/s10787-022-01001-2 PMC 바로가기 [Article Type] Randomized Controlled Trial
Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control studyCOVID-19 폐렴에 감염된 입원 환자의 렘데시비르 치료: 사례-대조군 연구Observational Study Published on 2022-08-012022-10-30 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 임상, 치료제, [키워드] Admission adverse event adverse events affected Analysis analyzed Antiviral antiviral therapy Antiviral treatment baseline characteristics case-control study Clinical outcome clinical outcomes control group coronavirus disease Coronavirus disease 2019 COVID-19 Efficacy Hospitalization hospitalized patient hospitalized patients ICU ICU admission in vitro activity intensive care intensive care unit lower mortality mortality rate Multivariate analysis observational study Odds ratio patients treated Remdesivir reported retrospective risk SARS-CoV-2 severe coronavirus disease significantly lower subject supportive therapies survival survival analysis treated Treatment two groups viruses with COVID-19 [DOI] 10.1002/jmv.27768 PMC 바로가기 [Article Type] Observational Study
Variations of COVID-19 mortality are affected by economic disparities across countriesCOVID-19 사망률의 변화는 국가 간 경제적 격차에 영향을 받습니다.Article Published on 2022-08-012022-09-11 Journal: The Science of the total environment [Category] SARS, 변종, [키워드] Affect affected average mortality Case fatality rate case fatality rates CFRs Clinical outcome clinical outcomes country COVID-19 COVID-19 case COVID-19 disease COVID-19 mitigation COVID-19 mortality cross-sectional cross-sectional study cumulative Dashboard death decreasing dominant Economy Efficiency exhibited Factor Factors First wave health system income Income levels increase in increased mortality management maximum medical resource Mitigation Mortality mortality rate mortality rates much lower outcome patients performed Policy population density populations Prevent reduction Region reported reversed second wave situation Stage the disease time lag Transmission Turning Turning points unit variant Wave Waves WHO Worldometer [DOI] 10.1016/j.scitotenv.2022.154770 PMC 바로가기 [Article Type] Article
Real-world effectiveness of casirivimab plus indevimab in a dedicated ambulatory unit created for patients with early COVID-19 during a massive delta variant wave대규모 델타 변이 파동 동안 초기 COVID-19 환자를 위해 만들어진 전용 보행 유닛에서 카시리비맙과 인데비맙의 실제 효과Article Published on 2022-08-012022-09-11 Journal: European Journal of Clinical Microbiology & Infect [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] age ambulatory Ambulatory care benefit Casirivimab Comorbidity COVID COVID-19 Delta delta variant duration of symptom early administration Effect Effectiveness high-risk patient High-risk patients Hospitalization life monoclonal antibodies mortality rate mortality rates Neutralizing antibodies neutralizing antibody neutralizing monoclonal antibodies neutralizing monoclonal antibody oxygen Oxygen requirement Patient prospectively studied Real life. supplemental oxygen variant [DOI] 10.1007/s10096-022-04474-9 PMC 바로가기 [Article Type] Article
Soluble CD137 as a potential biomarker for severe COVID-19Article Published on 2022-08-012022-10-05 Journal: Immunology letters [Category] 바이오마커, [키워드] 24 hour acute respiratory syndrome Analysis Biomarker Blood Brazil Care caused CD137 characterized Clinical outcome contagious Control coronavirus Coronavirus disease 2019 correlation COVID-19 critical COVID-19 patient Critically ill patient cytokine Cytokines demonstrated disease disease severity evaluate evaluated growth factor Growth factors Health healthy blood donors high risk highly pathogenic hospital ICU ICU admission identify immune increase in increased risk Infection intensive care isoform mechanical ventilation membrane-bound mortality rate Necrosis outcomes pandemic Potential biomarker potential therapy primary endpoint Prospective Study receptor recruitment regulate responsible SARS-CoV-2 severe COVID-19 severe SARS-CoV-2 severity Soluble CD137 Soluble immune checkpoints T-cell activation therapeutic targets TNF was related was used WHO with COVID-19 World Health Organization [DOI] 10.1016/j.imlet.2022.07.003 [Article Type] Article
Electrochemical genosensor for the specific detection of SARS-CoV-2SARS-CoV-2의 특정 검출을 위한 전기화학적 제노센서Article Published on 2022-08-012022-09-11 Journal: Talanta [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] alternative biotinylated capture caused cell cultures complex complexes coronavirus disease COVID-19 cultures detect Diagnosis diagnostic discrimination disease DNA-RNA followed by Genosensor homologous horseradish peroxidase imperative in vitro Increases limit of detection maleimide molecular mortality rate Nanobioconjugate pandemic Particles peroxidase probe probes respiratory respiratory viruses responsible SARS-CoV-2 SARS-CoV-2 cell SARS-CoV-2 detection sensitivity serological test Serological tests Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Signaling streptavidin Surveillance tested the patient virus [DOI] 10.1016/j.talanta.2022.123482 PMC 바로가기 [Article Type] Article
COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and ReviewCOVID-19 관련 점막 진균증: 기회주의적 진균 감염. 사례 시리즈 및 검토Review Published on 2022-08-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory distress acute respiratory distress syndrome B.1.617.2 blood sugar circulating Corticosteroid corticosteroid therapy Corticosteroids COVID-19 COVID-19 associated mucormycosis COVID-19 diagnosis COVID-19 variants delta variant diabetes Diabetes Mellitus diagnosed died Fungal infection glycemic control hospital immune dysfunction India Infection Intervention Invasive mold infections median time morbidity and mortality mortality rate MOST Mucorales Mucormycosis Oman opportunistic infection outcome Patient patients died reported respiratory distress review Rhino-orbital-cerebral mucormycosis Rhizopus Rhizopus oryzae. risk factor second wave Septic shock Sery severe acute respiratory distress syndrome severe COVID-19 sugar summer surgical surgical intervention syndrome uncontrolled use of corticosteroids variant [DOI] 10.1016/j.ijid.2022.05.005 PMC 바로가기 [Article Type] Review